Navigating Late-Stage Comparability From Phase One to BLA Submission Through Strategic Planning & Regulatory Engagement
- Implementing proactive comparability strategies during late-stage development to manage process changes and scale-out requirements while maintaining condensed BLA timelines
- Transitioning products from early clinical phases through commercial readiness by establishing robust comparability frameworks that satisfy evolving regulatory expectations
- Leveraging successful comparability case studies and strategic regulatory navigation approaches to prevent delays and ensure seamless progression toward commercial approval